BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3300989)

  • 1. Effect of nifedipine on glucose tolerance, serum insulin, and serum fructosamine in diabetic and nondiabetic patients.
    Gill JS; Al-Hussary N; Zezulka AV; Pasi KJ; Atkins TW; Beevers DG
    Clin Ther; 1987; 9(3):304-10. PubMed ID: 3300989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of nifedipine on carbohydrate metabolism in the non-insulin dependent diabetic].
    Abadie E; Villette JM; Gauville C; Tabuteau F; Fiet J; Passa P
    Diabete Metab; 1985 Jun; 11(3):141-6. PubMed ID: 3896885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of serum fructosamine and blood glucose concentrations as indices of glycaemic control in non-insulin dependent diabetic out-patients.
    Lim TO; Selvan T; Suppiah A; Khan N; Ismail F
    Singapore Med J; 1992 Jun; 33(3):287-9. PubMed ID: 1631590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
    Al-Waili N
    Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitrendipine does not impair long-term glucose control in hypertensive noninsulin-dependent diabetic patients.
    Giuntoli F; Galeone F; Gabbani S; Natali A; Brunelleschi G; Saba P; Stampino CG
    Clin Ther; 1991; 13(2):216-23. PubMed ID: 1907527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Does long-term blood pressure reduction in patients with essential hypertension improve concomitant metabolic disorders?].
    Hauner H; Meissner C
    Med Klin (Munich); 1994 Aug; 89(8):403-9. PubMed ID: 7968872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose tolerance during chronic propranolol treatment.
    Cressman MD; Vidt DG; Mohler H; Gifford RW
    J Clin Hypertens; 1985 Jun; 1(2):138-44. PubMed ID: 3915320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive therapy in diabetic patients. The use of indapamide.
    Harrower AD; McFarlane G
    Am J Med; 1988 Jan; 84(1B):89-91. PubMed ID: 3277423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of treatment on insulin release and relative peripheral resistance during the oral glucose tolerance test. A study of noninsulin-dependent diabetes mellitus and glucose intolerance.
    Cederholm J; Wibell L
    Diabete Metab; 1986 Feb; 12(1):10-5. PubMed ID: 3516748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of celiprolol on insulin sensitivity and glucose tolerance in dyslipidemic hypertension.
    Malminiemi K; Lahtela JT; Huupponen R
    Int J Clin Pharmacol Ther; 1995 Mar; 33(3):156-63. PubMed ID: 7599914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose metabolism in patients with essential hypertension.
    García-Puig J; Ruilope LM; Luque M; Fernández J; Ortega R; Dal-Ré R;
    Am J Med; 2006 Apr; 119(4):318-26. PubMed ID: 16564774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of captopril and captopril plus frusemide as antihypertensive agents in non-insulin dependent diabetes.
    Matthews DM; Wathen CG; Bell D; Collier A; Roulston JE; Clarke BF; Muir AL
    J Hum Hypertens; 1987 Jun; 1(1):19-23. PubMed ID: 3334054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible role for insulin receptors in the mechanism of thiazide induced glucose tolerance.
    Gill JS; Al-Hussary N; Atkins TW; Taylor KG; Beevers DG
    J Hypertens Suppl; 1984 Dec; 2(3):S573-6. PubMed ID: 6599719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects.
    Dominguez LJ; Barbagallo M; Kattah W; Garcia D; Sowers JR
    Am J Hypertens; 1995 Aug; 8(8):808-14. PubMed ID: 7576397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin versus glipizide treatment in patients with non-insulin-dependent diabetes mellitus. Effects on blood pressure and glucose tolerance.
    Levy J; Vandenberg M; Grunberger G
    Am J Hypertens; 1995 May; 8(5 Pt 1):445-53. PubMed ID: 7662219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of verapamil, diltiazem, nifedipine and propranolol on metabolic control in hypertensives with non-insulin dependent diabetes mellitus.
    Chellingsworth MC; Kendall MJ; Wright AD; Singh BM; Pasi J
    J Hum Hypertens; 1989 Feb; 3(1):35-9. PubMed ID: 2657057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Extracardiovascular effects of nifedipine in the treatment of hypertensive patients: glucose tolerance and behavior of immunoreactive insulin].
    Vulpis V; Antonacci A; Pirrelli A
    Cardiologia; 1988 Feb; 33(2):139-42. PubMed ID: 3282657
    [No Abstract]   [Full Text] [Related]  

  • 18. Fructosamine as a possible monitoring parameter in non-insulin dependent diabetes mellitus patients with periodontal disease.
    Unal T; Firatli E; Sivas A; Meric H; Oz H
    J Periodontol; 1993 Mar; 64(3):191-4. PubMed ID: 8463941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum fructosamine studies in pediatric diabetology].
    Acsai L; Szoboszlay I; Petheö I
    Orv Hetil; 1989 Oct; 130(40):2147-50. PubMed ID: 2694056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin secretion and glucose tolerance in non-insulin dependent diabetic patients after chronic nifedipine treatment.
    Tentorio A; Ghilardi G; Pedroncelli A; Benco R; Stroppa S; Adib S; Gianola D; Pagani G
    Eur J Clin Pharmacol; 1989; 36(3):311-3. PubMed ID: 2663524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.